Back to School: How biopharma can reboot drug development. Access exclusive analysis here

$24M gift for allergy research at Stanford

Silicon Valley entrepreneur Sean Parker pledged $24 million over the next two years to establish a research center at the

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE